Scully, M., Cataland, S., Peyvandi, F., Coppo, P., Knöbl, P., Hovinga, J., . . . Zeldin, R. (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Citación estilo ChicagoScully, M., et al. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. 2019.
Cita MLAScully, M., et al. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. 2019.
Precaución: Estas citas no son 100% exactas.